Estrogen receptor protein in breast cancer as a predictor of recurrence

Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP‐positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary node...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1981-05, Vol.47 (10), p.2364-2367
Main Authors: Kinne, David W., Ashikari, Roy, Butler, Avital, Menendez‐Botet, Celia, Rosen, Paul Peter, Schwartz, Morton
Format: Article
Language:English
Subjects:
Breast Neoplasms - analysis
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Female
Humans
Mastectomy
Middle Aged
Neoplasm Recurrence, Local
Probability
Prognosis
Receptors, Estrogen - analysis
Receptors, Progesterone - analysis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4727-8ea7763a28fbbbc1417f5a1e9780a34f696554750e1aa355009abc26e0e9a57e3
container_end_page 2367
container_issue 10
container_start_page 2364
container_title Cancer
container_volume 47
creator Kinne, David W.
Ashikari, Roy
Butler, Avital
Menendez‐Botet, Celia
Rosen, Paul Peter
Schwartz, Morton
description Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP‐positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP‐positive patients who recurred had a better survival. ERP did not influence response to adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.
doi_str_mv 10.1002/1097-0142(19810515)47:10<2364::AID-CNCR2820471007>3.0.CO;2-S
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73637215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73637215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4727-8ea7763a28fbbbc1417f5a1e9780a34f696554750e1aa355009abc26e0e9a57e3</originalsourceid><addsrcrecordid>eNqVkFtL5EAQhRtx0fHyE4Q8ifuQsfqWTkZZGOJlBXFgXcEHoei0FYnMTMbuDOK_t8OMgj4sLDQUzTmnTvExdsZhyAHEMYfCpMCVOOJFzkFz_VOZEYdTITM1Go2vztLypvwjcgHKxIT5JYcwLCcnIr3dYIPP-CYbAECeaiXvt9lOCM_xa4SWW2zLCCPyQgzY5XnofPtE88STo0XX-mTh246aeRJf5cmGLnF27sgnNiQ2qvTYuN7X1n1m6T1FdY_9qO000P567rK7i_O_5e_0enJ5VY6vU6diZ5qTNSaTVuR1VVWOK25qbTkVJgcrVZ0VmdbKaCBurdQaoLCVExkBFVYbkrvscLU3XvmypNDhrAmOplM7p3YZ0MhMGsF1ND6sjM63IXiqceGbmfVvyAF7ztiDwh4UfnBGZXq154wYOeNXzigRsJygwNu4_mB9x7Ka0ePn8jXYqD-t9NdmSm__2f3P6m-KfAcZNppz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73637215</pqid></control><display><type>article</type><title>Estrogen receptor protein in breast cancer as a predictor of recurrence</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kinne, David W. ; Ashikari, Roy ; Butler, Avital ; Menendez‐Botet, Celia ; Rosen, Paul Peter ; Schwartz, Morton</creator><creatorcontrib>Kinne, David W. ; Ashikari, Roy ; Butler, Avital ; Menendez‐Botet, Celia ; Rosen, Paul Peter ; Schwartz, Morton</creatorcontrib><description>Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP‐positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP‐positive patients who recurred had a better survival. ERP did not influence response to adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19810515)47:10&lt;2364::AID-CNCR2820471007&gt;3.0.CO;2-S</identifier><identifier>PMID: 7272892</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Breast Neoplasms - analysis ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Female ; Humans ; Mastectomy ; Middle Aged ; Neoplasm Recurrence, Local ; Probability ; Prognosis ; Receptors, Estrogen - analysis ; Receptors, Progesterone - analysis</subject><ispartof>Cancer, 1981-05, Vol.47 (10), p.2364-2367</ispartof><rights>Copyright © 1981 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4727-8ea7763a28fbbbc1417f5a1e9780a34f696554750e1aa355009abc26e0e9a57e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7272892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kinne, David W.</creatorcontrib><creatorcontrib>Ashikari, Roy</creatorcontrib><creatorcontrib>Butler, Avital</creatorcontrib><creatorcontrib>Menendez‐Botet, Celia</creatorcontrib><creatorcontrib>Rosen, Paul Peter</creatorcontrib><creatorcontrib>Schwartz, Morton</creatorcontrib><title>Estrogen receptor protein in breast cancer as a predictor of recurrence</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP‐positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP‐positive patients who recurred had a better survival. ERP did not influence response to adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.</description><subject>Breast Neoplasms - analysis</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Mastectomy</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Probability</subject><subject>Prognosis</subject><subject>Receptors, Estrogen - analysis</subject><subject>Receptors, Progesterone - analysis</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><recordid>eNqVkFtL5EAQhRtx0fHyE4Q8ifuQsfqWTkZZGOJlBXFgXcEHoei0FYnMTMbuDOK_t8OMgj4sLDQUzTmnTvExdsZhyAHEMYfCpMCVOOJFzkFz_VOZEYdTITM1Go2vztLypvwjcgHKxIT5JYcwLCcnIr3dYIPP-CYbAECeaiXvt9lOCM_xa4SWW2zLCCPyQgzY5XnofPtE88STo0XX-mTh246aeRJf5cmGLnF27sgnNiQ2qvTYuN7X1n1m6T1FdY_9qO000P567rK7i_O_5e_0enJ5VY6vU6diZ5qTNSaTVuR1VVWOK25qbTkVJgcrVZ0VmdbKaCBurdQaoLCVExkBFVYbkrvscLU3XvmypNDhrAmOplM7p3YZ0MhMGsF1ND6sjM63IXiqceGbmfVvyAF7ztiDwh4UfnBGZXq154wYOeNXzigRsJygwNu4_mB9x7Ka0ePn8jXYqD-t9NdmSm__2f3P6m-KfAcZNppz</recordid><startdate>19810515</startdate><enddate>19810515</enddate><creator>Kinne, David W.</creator><creator>Ashikari, Roy</creator><creator>Butler, Avital</creator><creator>Menendez‐Botet, Celia</creator><creator>Rosen, Paul Peter</creator><creator>Schwartz, Morton</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19810515</creationdate><title>Estrogen receptor protein in breast cancer as a predictor of recurrence</title><author>Kinne, David W. ; Ashikari, Roy ; Butler, Avital ; Menendez‐Botet, Celia ; Rosen, Paul Peter ; Schwartz, Morton</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4727-8ea7763a28fbbbc1417f5a1e9780a34f696554750e1aa355009abc26e0e9a57e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Breast Neoplasms - analysis</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Mastectomy</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Probability</topic><topic>Prognosis</topic><topic>Receptors, Estrogen - analysis</topic><topic>Receptors, Progesterone - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kinne, David W.</creatorcontrib><creatorcontrib>Ashikari, Roy</creatorcontrib><creatorcontrib>Butler, Avital</creatorcontrib><creatorcontrib>Menendez‐Botet, Celia</creatorcontrib><creatorcontrib>Rosen, Paul Peter</creatorcontrib><creatorcontrib>Schwartz, Morton</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kinne, David W.</au><au>Ashikari, Roy</au><au>Butler, Avital</au><au>Menendez‐Botet, Celia</au><au>Rosen, Paul Peter</au><au>Schwartz, Morton</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estrogen receptor protein in breast cancer as a predictor of recurrence</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1981-05-15</date><risdate>1981</risdate><volume>47</volume><issue>10</issue><spage>2364</spage><epage>2367</epage><pages>2364-2367</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Estrogen receptor protein (ERP) determinations of primary cancers of 1034 patients with primary breast cancer were done. ERP‐positive patients tended to have a lower recurrence rate and had significantly improved survival. This difference was most apparent in patients with four or more axillary nodes involved. ERP‐positive patients who recurred had a better survival. ERP did not influence response to adjuvant chemotherapy, nor did the presence of progesterone receptor or femtomole level of ERP affect recurrence.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7272892</pmid><doi>10.1002/1097-0142(19810515)47:10&lt;2364::AID-CNCR2820471007&gt;3.0.CO;2-S</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1981-05, Vol.47 (10), p.2364-2367
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_73637215
source EZB-FREE-00999 freely available EZB journals
subjects Breast Neoplasms - analysis
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Female
Humans
Mastectomy
Middle Aged
Neoplasm Recurrence, Local
Probability
Prognosis
Receptors, Estrogen - analysis
Receptors, Progesterone - analysis
title Estrogen receptor protein in breast cancer as a predictor of recurrence
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A56%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estrogen%20receptor%20protein%20in%20breast%20cancer%20as%20a%20predictor%20of%20recurrence&rft.jtitle=Cancer&rft.au=Kinne,%20David%20W.&rft.date=1981-05-15&rft.volume=47&rft.issue=10&rft.spage=2364&rft.epage=2367&rft.pages=2364-2367&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19810515)47:10%3C2364::AID-CNCR2820471007%3E3.0.CO;2-S&rft_dat=%3Cproquest_cross%3E73637215%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4727-8ea7763a28fbbbc1417f5a1e9780a34f696554750e1aa355009abc26e0e9a57e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73637215&rft_id=info:pmid/7272892&rfr_iscdi=true